The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countriesJohanna Abelsson, Mats Merup, Gunnar Birgegård et al.|Bone Marrow Transplantation|2011Cited by 70
Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow‐upErik Ahlstrand, Björn Andréasson, Maria Liljeholm et al.|European Journal Of Haematology|2019Cited by 13
Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based studyAnneli Enblom‐Larsson, Anders Själander, Henrik Renlund et al.|British Journal of Haematology|2024Cited by 11
Thrombosis, major bleeding, and mortality in 1079 patients with myelofibrosis: a matched population-based studyAnneli Enblom‐Larsson, Anders Själander, Henrik Renlund et al.|Blood Advances|2025Cited by 8
Erythrocytosis, thrombocytosis, and rate of recurrent thromboembolic event—A population based cohort studyAnneli Enblom‐Larsson, Anders Själander, Björn Andréasson et al.|European Journal Of Haematology|2023Cited by 3